Ontology type: schema:ScholarlyArticle Open Access: True
2016-12
AUTHORSH. J. Gray, B. Benigno, J. Berek, J. Chang, J. Mason, L. Mileshkin, P. Mitchell, M. Moradi, F. O. Recio, C. M. Michener, A. Alvarez Secord, N E. Tchabo, J. K. Chan, J. Young, H. Kohrt, S. E. Gargosky, J. C. Goh
ABSTRACTBACKGROUND: CAN-003 was a randomized, open-label, Phase 2 trial evaluating the safety, efficacy and immune outcomes of CVac, a mucin 1 targeted-dendritic cell (DC) treatment as a maintenance therapy to patients with epithelial ovarian cancer (EOC). METHODS: Patients (n = 56) in first (CR1) or second clinical remission (CR2) were randomized (1:1) to standard of care (SOC) observation or CVac maintenance treatment. Ten doses were administered over 56 weeks. Both groups were followed for progression-free survival (PFS) and overall survival (OS). RESULTS: Fifty-six patients were randomized: 27 to SOC and 29 to CVac. Therapy was safe with only seven patients with Grade 3-4 treatment-emergent adverse events. A variable but measurable mucin 1 T cell-specific response was induced in all CVac-treated and some standard of care (SOC) patients. Progression free survival (PFS) was not significantly longer in the treated group compared to SOC group (13 vs. 9 months, p = 0.36, hazard ratio [HR] = 0.73). Analysis by remission status showed in the CR1 subgroup a median PFS of 18 months (SOC) vs. 13 months (CVac); p = 0.69 (HR = 1.18; CI 0.52-2.71). However CR2 patients showed a longer median PFS in the CVac-treated group (median PFS not yet reached, >13 vs. 5 months; p = 0.04, HR = 0.32 CI). OS for CR2 patients at 42 months of follow-up showed a difference of 26 months for SOC vs. > 42 months for CVac-treated (as median OS had not been reached; HR = 0.17 (CI 0.02-1.4) with a p = 0.07). CONCLUSIONS: CVac, a mucin 1-dendritic cell maintenance treatment was safe and well tolerated in ovarian cancer patients. A variable but observed CVac-derived, mucin 1-specific T cell response was measured. Notably, CR2 patients showed an improved PFS and lengthened OS. Further studies in CR2 ovarian cancer patients are warranted (NCT01068509). TRIAL REGISTRATION: NCT01068509. Study Initiation Date (first patient screened): 20 July 2010. Study Completion Date (last patient observation): 20 August 2013, the last patient observation for progression-free survival; 29 April 2015, the last patient was documented regarding overall survival. More... »
PAGES34
http://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x
DOIhttp://dx.doi.org/10.1186/s40425-016-0137-x
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1033181369
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/27330807
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "University of Washington Medical Center",
"id": "https://www.grid.ac/institutes/grid.412623.0",
"name": [
"University of Washington Medical Center, Seattle, WA, USA"
],
"type": "Organization"
},
"familyName": "Gray",
"givenName": "H. J.",
"id": "sg:person.0735642527.91",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735642527.91"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Northside Hospital",
"id": "https://www.grid.ac/institutes/grid.416555.6",
"name": [
"Northside Hospital, Atlanta, GA, USA"
],
"type": "Organization"
},
"familyName": "Benigno",
"givenName": "B.",
"id": "sg:person.01301461705.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301461705.19"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Stanford Women\u2019s Cancer Center, Stanford, CA, USA"
],
"type": "Organization"
},
"familyName": "Berek",
"givenName": "J.",
"id": "sg:person.010516421017.70",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010516421017.70"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Marin Cancer Care, Greenbrae, CA, USA"
],
"type": "Organization"
},
"familyName": "Chang",
"givenName": "J.",
"id": "sg:person.014767761117.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014767761117.36"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Scripps Health",
"id": "https://www.grid.ac/institutes/grid.419722.b",
"name": [
"Scripps Cancer Center, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Mason",
"givenName": "J.",
"id": "sg:person.012011361041.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012011361041.38"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Peter MacCallum Cancer Centre",
"id": "https://www.grid.ac/institutes/grid.1055.1",
"name": [
"Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia"
],
"type": "Organization"
},
"familyName": "Mileshkin",
"givenName": "L.",
"id": "sg:person.01306256505.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306256505.25"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Austin Health",
"id": "https://www.grid.ac/institutes/grid.410678.c",
"name": [
"Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic, Australia"
],
"type": "Organization"
},
"familyName": "Mitchell",
"givenName": "P.",
"id": "sg:person.01240411533.17",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240411533.17"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lower Manhattan Hospital",
"id": "https://www.grid.ac/institutes/grid.416112.1",
"name": [
"New York Downtown Hospital, New York, NY, USA"
],
"type": "Organization"
},
"familyName": "Moradi",
"givenName": "M.",
"id": "sg:person.014201702441.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014201702441.54"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"South Florida Center for Gynecologic Oncology, Boca Raton, FL, USA"
],
"type": "Organization"
},
"familyName": "Recio",
"givenName": "F. O.",
"id": "sg:person.0766200410.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766200410.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cleveland Clinic",
"id": "https://www.grid.ac/institutes/grid.239578.2",
"name": [
"Cleveland Clinic Foundation, Cleveland, OH, USA"
],
"type": "Organization"
},
"familyName": "Michener",
"givenName": "C. M.",
"id": "sg:person.01240016453.32",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240016453.32"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Duke University",
"id": "https://www.grid.ac/institutes/grid.26009.3d",
"name": [
"Duke Cancer Institute, Duke University Health System, Durham, NC, USA"
],
"type": "Organization"
},
"familyName": "Secord",
"givenName": "A. Alvarez",
"id": "sg:person.01153251200.71",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153251200.71"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Morristown Medical Center",
"id": "https://www.grid.ac/institutes/grid.416113.0",
"name": [
"Morristown Medical Center, Morristown, NJ, USA"
],
"type": "Organization"
},
"familyName": "Tchabo",
"givenName": "N E.",
"id": "sg:person.01206754423.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206754423.19"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of California, San Francisco",
"id": "https://www.grid.ac/institutes/grid.266102.1",
"name": [
"University of California, San Francisco & Sutter Health Research Institute, San Francisco, CA, USA"
],
"type": "Organization"
},
"familyName": "Chan",
"givenName": "J. K.",
"id": "sg:person.013072753512.00",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013072753512.00"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Medical University of South Carolina",
"id": "https://www.grid.ac/institutes/grid.259828.c",
"name": [
"Medical University of South Carolina, Charleston, SC, USA"
],
"type": "Organization"
},
"familyName": "Young",
"givenName": "J.",
"id": "sg:person.011262113641.15",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011262113641.15"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Stanford University",
"id": "https://www.grid.ac/institutes/grid.168010.e",
"name": [
"Stanford University Cancer Institute, Stanford, CA, USA"
],
"type": "Organization"
},
"familyName": "Kohrt",
"givenName": "H.",
"id": "sg:person.01144535603.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144535603.40"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Prima BioMed, Sydney, NSW, Australia"
],
"type": "Organization"
},
"familyName": "Gargosky",
"givenName": "S. E.",
"id": "sg:person.01116001617.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116001617.09"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Greenslopes Private Hospital, Royal Brisbane & Women\u2019s Hospital, University of Queensland & Gallipoli Research Foundation, Greenslopes, QLD, Australia"
],
"type": "Organization"
},
"familyName": "Goh",
"givenName": "J. C.",
"id": "sg:person.013452435241.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013452435241.07"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1056/nejmoa1507643",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000663586"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/2051-1426-2-16",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007070580",
"https://doi.org/10.1186/2051-1426-2-16"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/2051-1426-2-16",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007070580",
"https://doi.org/10.1186/2051-1426-2-16"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ygyno.2007.02.004",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009417955"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-05-1574",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009558049"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1021/jm5018237",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010331914"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.jcyt.2013.01.184",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014256254"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/2051-1426-1-s1-p213",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018712024",
"https://doi.org/10.1186/2051-1426-1-s1-p213"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1510665",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019970557"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2006.09.4540",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020656211"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1309/9r6673qec06d86y4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021159180"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ejca.2008.10.026",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026558254"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2217/imt.10.17",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032207164"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1104390",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035779003"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1104390",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035779003"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/jnci/92.18.1534",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038214940"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2217/fon.14.313",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038967503"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2014.55.7348",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051247162"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1103799",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052109861"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1103799",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052109861"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1504627",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052572745"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00018-015-2014-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053537243",
"https://doi.org/10.1007/s00018-015-2014-z"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1517/14712598.2015.1088519",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1067589143"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1615/critrevimmunol.v14.i3-4.40",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1068131598"
],
"type": "CreativeWork"
}
],
"datePublished": "2016-12",
"datePublishedReg": "2016-12-01",
"description": "BACKGROUND: CAN-003 was a randomized, open-label, Phase 2 trial evaluating the safety, efficacy and immune outcomes of CVac, a mucin 1 targeted-dendritic cell (DC) treatment as a maintenance therapy to patients with epithelial ovarian cancer (EOC).\nMETHODS: Patients (n\u2009=\u200956) in first (CR1) or second clinical remission (CR2) were randomized (1:1) to standard of care (SOC) observation or CVac maintenance treatment. Ten doses were administered over 56\u00a0weeks. Both groups were followed for progression-free survival (PFS) and overall survival (OS).\nRESULTS: Fifty-six patients were randomized: 27 to SOC and 29 to CVac. Therapy was safe with only seven patients with Grade 3-4 treatment-emergent adverse events. A variable but measurable mucin 1\u00a0T cell-specific response was induced in all CVac-treated and some standard of care (SOC) patients. Progression free survival (PFS) was not significantly longer in the treated group compared to SOC group (13 vs. 9\u00a0months, p\u2009=\u20090.36, hazard ratio [HR]\u2009=\u20090.73). Analysis by remission status showed in the CR1 subgroup a median PFS of 18\u00a0months (SOC) vs. 13\u00a0months (CVac); p\u2009=\u20090.69 (HR\u2009=\u20091.18; CI 0.52-2.71). However CR2 patients showed a longer median PFS in the CVac-treated group (median PFS not yet reached, >13 vs. 5\u00a0months; p\u2009=\u20090.04, HR\u2009=\u20090.32 CI). OS for CR2 patients at 42\u00a0months of follow-up showed a difference of 26\u00a0months for SOC vs. > 42\u00a0months for CVac-treated (as median OS had not been reached; HR\u2009=\u20090.17 (CI 0.02-1.4) with a p\u2009=\u20090.07).\nCONCLUSIONS: CVac, a mucin 1-dendritic cell maintenance treatment was safe and well tolerated in ovarian cancer patients. A variable but observed CVac-derived, mucin 1-specific T cell response was measured. Notably, CR2 patients showed an improved PFS and lengthened OS. Further studies in CR2 ovarian cancer patients are warranted (NCT01068509).\nTRIAL REGISTRATION: NCT01068509. Study Initiation Date (first patient screened): 20 July 2010. Study Completion Date (last patient observation): 20 August 2013, the last patient observation for progression-free survival; 29 April 2015, the last patient was documented regarding overall survival.",
"genre": "research_article",
"id": "sg:pub.10.1186/s40425-016-0137-x",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2475889",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1049249",
"issn": [
"2051-1426"
],
"name": "Journal for ImmunoTherapy of Cancer",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "4"
}
],
"name": "Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial",
"pagination": "34",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"9e11f68fab3ce7c34f24b16f4cc36500c817ea24d3db7e990152e8b0e0bdfd8a"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"27330807"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"101620585"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s40425-016-0137-x"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1033181369"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s40425-016-0137-x",
"https://app.dimensions.ai/details/publication/pub.1033181369"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T12:38",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70040_00000001.jsonl",
"type": "ScholarlyArticle",
"url": "https://link.springer.com/10.1186%2Fs40425-016-0137-x"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x'
This table displays all metadata directly associated to this object as RDF triples.
291 TRIPLES
21 PREDICATES
50 URIs
21 LITERALS
9 BLANK NODES